CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larsson, S. C.
Right arrow Articles by Wolk, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsson, S. C.
Right arrow Articles by Wolk, A.
Cancer Epidemiology Biomarkers & Prevention Vol. 15, 1409-1412, July 2006
© 2006 American Association for Cancer Research

Short Communication

Folate Intake and Stomach Cancer Incidence in a Prospective Cohort of Swedish Women

Susanna C. Larsson1, Edward Giovannucci2 and Alicja Wolk1

1 Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden and 2 Departments of Nutrition and Epidemiology, Harvard School of Public Health and Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts

Requests for reprints: Susanna C. Larsson, Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, P.O. Box 210, SE-17177 Stockholm, Sweden. Phone: 46-8-52486059; Fax: 46-8-304571. E-mail: susanna.larsson{at}ki.se


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Background: Experimental and epidemiologic evidence suggests that folate may play a role in the development of some cancers. Case-control studies and one prospective cohort study on folate intake in relation to stomach cancer risk have yielded inconsistent results.

Methods: We prospectively investigated the relation between folate intake and the incidence of stomach cancer among 61,433 women in the Swedish Mammography Cohort. Participants completed a food frequency questionnaire at baseline (1987-1990) and again in 1997. During follow-up through December 2004, 156 incident stomach cancer cases were diagnosed. Cox proportional hazards models were used to calculate multivariate-adjusted hazard ratios.

Results: There was no association between dietary folate intake (i.e., folate from food sources) and the risk of stomach cancer. The multivariate hazard ratio for the highest compared with the lowest category of updated average dietary folate intake was 1.04 (95% confidence interval, 0.61-1.86; Ptrend = 0.91). The relation between dietary folate intake and stomach cancer did not vary significantly by intake of alcohol, methionine, or caffeine.

Conclusion: Results from this prospective study do not support an association between dietary folate intake and risk of stomach cancer. (Cancer Epidemiol Biomarkers Prev 2006;15(7):1409–12)


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Dietary factors are supposed to play an important role in the etiology of stomach cancer (1). The most abundant evidence for an effect of diet on stomach cancer incidence has been related to a lower risk with greater consumption of fruits and vegetables (1, 2). Fruits and vegetables are major sources of folate, which has been inversely associated with risk of various cancers (3-12). Folate is a methyl group donor involved in both methylation and DNA synthesis pathways, and aberrations in either of these pathways may lead to cancer (13-15).

Epidemiologic studies concerning folate intake and risk of stomach cancer have yielded inconsistent results. Although some case-control studies have found a statistically significant inverse association between folate intake and stomach cancer risk (16-18), other case-control studies failed to show such an association (19-23). Only one previous prospective cohort study has reported on the association of folate intake with stomach cancer risk, and that study showed no association (24). To our knowledge, no previous study have examined whether the relation between folate and stomach cancer risk is modified by consumption of alcohol, which impairs folate metabolism (25, 26) and has been reported to modify the association between folate and risk of colon (27), breast (5, 6), and ovarian cancer (7).

In the present study, we sought to evaluate prospectively the association of folate intake, using repeated measures of diet, with risk of stomach cancer in the Swedish Mammography Cohort, a population-based prospective study with 18 years of follow-up. We also examined whether this relation was modified by intake of alcohol, methionine, or caffeine.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Study Population
The Swedish Mammography Cohort was established between 1987 and 1990, when all 90,303 women who were born between 1914 and 1948 and residing in two counties (Västmanland and Uppsala counties) in central Sweden received a mailed questionnaire concerning diet, weight, height, and education (28); 66,651 women responded to the questionnaire (74% response rate). A follow-up questionnaire was sent to all 56,030 participants who were still alive and living in the study area in the autumn of 1997 to update dietary data and to collect information on other lifestyle factors; 39,227 women returned a completed questionnaire (70% response rate). This study was approved by the Regional Ethical Review Board in Stockholm, Sweden.

Dietary Assessment
A food frequency questionnaire with 67 and 96 food items was sent to women at baseline and in 1997, respectively, to assess usual dietary intake. Women were asked how often, on average, they had consumed each type of food during the previous year. Nutrient intakes were computed by multiplying the consumption frequency of each food by the nutrient content of age-specific portion sizes, using composition values obtained from the Swedish Food Administration Database (29). The 1997 questionnaire also asked for information on the use of multivitamins and folic acid supplements. Total folate intake was calculated by summing intake of folate from foods and supplements. All nutrients were adjusted for total energy intake by using the residual method (30). In a random subsample of 129 women from the study population, the correlation coefficient for correlations between dietary folate intakes recorded on the baseline food frequency questionnaire compared with four 1-week weighed diet records was 0.50.

Case Ascertainment and Follow-up
We ascertained incident stomach cancer cases (International Classification of Diseases, Ninth Revision code 151) by computerized linkage of the study cohort with the national and regional Swedish Cancer registers. The Swedish cancer registers provide close to 100% complete case coverage (31, 32). Dates of death and migration were obtained by computerized linkage to the Swedish Death and Population registers at Statistics Sweden.

Analytic Cohort
For these analyses, we excluded from the baseline cohort women who were outside the age range of 40 through 76 years (n = 165), those with missing (n = 707) or incorrect identification numbers (n = 413), and those lacking date on the questionnaire (n = 608), date of moving out of the study area (n = 79), or date of death (n = 16). After further exclusion of women with implausible values for energy intake (i.e., 3 SDs from the mean value for loge-transformed energy, n = 793) and those with a cancer diagnosis (other than nonmelanoma skin cancer) before baseline (n = 2,437), the analytic cohort for the primary analyses consisted of 61,433 women. Of the 39,227 women who completed the 1997 questionnaire, 36,664 women were cancer-free as of December 1997 and had adequately completed the 1997 food frequency questionnaire.

Statistical Analysis
Women were categorized into quartiles according to their dietary folate intake at baseline. In our primary analyses, we calculated cumulative averaged dietary folate intake using both the baseline and 1997 dietary data to better reflect long-term intake and to reduce random within-person variation (33). Specifically, dietary data from the baseline questionnaire was used to predict stomach cancers diagnosed from baseline through 1997, and the average of the baseline and 1997 intake was used to predict outcomes from 1998 through 2004. If data from the 1997 questionnaire was not available, dietary data from the baseline questionnaire was used for the entire follow-up. In a secondary analysis, we used data from the baseline questionnaire only (without updating and averaging diet). In a subanalysis including women who completed the 1997 questionnaire, total folate intake (categorized into tertiles) in 1997 was used to predict stomach cancers diagnosed from 1998 through 2004.

For each participant, follow-up time accrued from the date of enrollment (for analyses of dietary folate intake) or January 1, 1998 (for analyses of total folate intake) and ended at the date of diagnosis of stomach cancer, death, migration, or December 31, 2004, whichever came first. We used Cox proportional hazards models (34) to estimate hazard ratios with 95% confidence intervals. Age in months and year of enrollment were used as stratification variables within each Cox model. In multivariate models, we controlled for age, education, and intakes of total energy, alcohol, vitamin C, ß-carotene, coffee, and tea. Variables examined but not included in the final model because they did not alter the association between folate intake and stomach cancer risk were body mass index, cigarette smoking, and consumption of fruits, vegetables, red meat, processed meat, and white meat. Tests based on the log likelihood ratio test and graphical methods showed no evidence that the proportional hazards assumption was violated for any analysis.

Tests for trend across quartiles of folate intake were conducted by modeling the median values of each quartile as a continuous variable. We did an additional analysis excluding the first 3 years of follow-up to remove early cases in whom the association between dietary folate intake and stomach cancer risk may have been biased because of changes in diet due to preclinical symptoms. We conducted analyses stratified by potential effect modifiers, including alcohol, methionine, and caffeine intake (the median intake of these dietary factors was used as a cutoff point). The likelihood ratio test was used to assess the significance of the interactions. Analyses were conducted with SAS statistical software (version 9.1; SAS Institute, Inc., Cary, NC). All Ps were two sided.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Table 1 shows the baseline characteristics of the study population according to dietary folate intake at baseline. The median daily dietary folate intake at baseline and in 1997 was 230 µg (interquartile range, 203-260 µg) and 270 µg (interquartile range, 228-319 µg), respectively. Compared with women in the lowest quartile of dietary folate intake, those with higher intakes were older and more likely to have a post-secondary education but were less likely to be nondrinkers of alcohol. Higher dietary folate was associated with greater intakes of vitamin C, ß-carotene, and tea, and with lower consumption of coffee and alcohol (among drinkers).


View this table:
[in this window]
[in a new window]
  		Table 1. Age-standardized baseline characteristics according to quartiles of energy-adjusted dietary folate intake at baseline, the Swedish Mammography Cohort (1987-1990)

 
Among 61,433 women followed-up for a total of 903,586 person-years, from 1987 through 2004, we ascertained 156 incident cases of stomach cancer (76 cases were diagnosed from baseline through 1997, and 80 cases were diagnosed from 1998 through 2004). There was no association between baseline or updated average dietary folate intake and the risk of stomach cancer in age-adjusted or multivariate analyses (Table 2 ). In a multivariate analysis of updated average dietary folate intake, the hazard ratio comparing the highest with the lowest quartile of intake was 1.04 (95% confidence interval, 0.61-1.86). Excluding the first 3 years of follow-up did not change the results materially (multivariate hazard ratio, 1.01; 95% confidence interval, 0.55-1.91). The association between dietary folate intake and stomach cancer was not significantly modified by intake of alcohol (Pinteraction = 0.17), methionine (Pinteraction = 0.83), or caffeine (Pinteraction = 0.98).


View this table:
[in this window]
[in a new window]
  		Table 2. Age- and multivariate-adjusted hazard ratios and 95% confidence intervals of stomach cancer according to dietary folate intake based on baseline and updated average intakes in the Swedish Mammography Cohort (1987-2004)

 
In a subanalysis using data from the 1997 questionnaire, we found no significant association between total folate intake (i.e., folate from foods and dietary supplements) and stomach cancer risk. The multivariate hazard ratios (adjusted for the same variables as in Table 2) for the highest versus the lowest tertile of total folate intake was 0.88 (95% confidence interval, 0.40-1.93).


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
In this population-based prospective cohort of Swedish women with 18 years of follow-up and repeated measures of diet, we observed no association between dietary folate intake and risk of stomach cancer. This relation was not modified by intake of alcohol, methionine, or caffeine.

Results from previous epidemiologic studies concerning the relation between folate intake and risk of stomach cancer have been inconsistent. Our overall null findings are consistent with results from the only other prospective cohort study of folate intake and risk of stomach cancer (24). In the Netherlands Cohort Study with 6.3 years of follow-up, the multivariate relative risk for the top versus the bottom quintile of baseline folate intake was 1.0 (24). Five case-control studies also observed no significant association between folate intake and stomach cancer risk (19-23). However, three other case-control studies carried out in the United States (17, 18) and Spain (16) reported a statistically significant 30% to 50% reduction in stomach cancer risk for the highest versus the lowest category of folate intake. A high folate intake was associated with a nonsignificant lower risk of stomach cancer in an Italian case-control study of subjects with a family history of gastric cancer (35).

The major strengths of our study include its population-based and prospective design, the availability of dietary exposure information collected from participants at two time points, and the virtually complete follow-up of the cohort through linkage with computerized population-based registers of cancer and deaths. The prospective collection of information eliminates the possibility of biased recall of diet, and the practically complete cohort follow-up minimizes the likelihood of bias caused by differential loss-to-follow-up. Repeated assessments of diet were used in our primary analyses, which provide a better measure of long-term intake than does our baseline diet although associations with stomach cancer risk were not different for baseline and updated diet. Limitations of this study include an inability to examine the association between folate intake and stomach cancer risk by anatomic or histologic subtype, or by Helicobacter pylori infection status. Because diet was assessed with a self-administered food frequency questionnaire, and because information on dietary supplement use was not collected at baseline, some degree of misclassification of folate intake was inevitable, which would tend to attenuate any true association of folate intake with risk of stomach cancer. Although we found no significant relationship between total folate intake and risk of stomach cancer in a subanalysis using data from the 1997 questionnaire (which inquired about supplement use), we cannot rule out that we missed a weak association due to lack of statistical power.

In summary, the findings from this population-based prospective cohort of women do not support an association between folate intake and risk of stomach cancer. Future studies should examine whether this relation varies by anatomic subsite, histologic subtype, and possibly by H. pylori infection status.


   Footnotes
 
Grant support: Swedish Research Council/Longitudinal Studies, Swedish Cancer Foundation, and Swedish Foundation for International Cooperation in Research and Higher Education.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 10/24/05; revised 4/14/06; accepted 5/12/06.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. World Cancer Research Fund, American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: a global perspective. Washington (DC): American Institute for Cancer Research; 1997.
  2. IARC handbooks of cancer prevention, vol. 8. Fruit and vegetables. Lyon (France): IARC Press; 2003.
  3. Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 2005;113:825–8.[CrossRef][Medline]
  4. Larsson SC, Giovannucci E, Wolk A. A prospective study of dietary folate intake and risk of colorectal cancer: modification by caffeine intake and cigarette smoking. Cancer Epidemiol Biomarkers Prev 2005;14:740–3.[Abstract/Free Full Text]
  5. Rohan TE, Jain MG, Howe GR, Miller AB. Dietary folate consumption and breast cancer risk. J Natl Cancer Inst 2000;92:266–9.[Free Full Text]
  6. Zhang SM, Willett WC, Selhub J, et al. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst 2003;95:373–80.[Abstract/Free Full Text]
  7. Larsson SC, Giovannucci E, Wolk A. Dietary folate intake and incidence of ovarian cancer: the Swedish Mammography Cohort. J Natl Cancer Inst 2004;96:396–402.[Abstract/Free Full Text]
  8. Pelucchi C, Talamini R, Negri E, et al. Folate intake and risk of oral and pharyngeal cancer. Ann Oncol 2003;14:1677–81.[Abstract/Free Full Text]
  9. Bidoli E, Bosetti C, La Vecchia C, et al. Micronutrients and laryngeal cancer risk in Italy and Switzerland: a case-control study. Cancer Causes Control 2003;14:477–84.[CrossRef][Medline]
  10. Galeone C, Pelucchi C, Levi F, et al. Folate intake and squamous-cell carcinoma of the oesophagus in Italian and Swiss men. Ann Oncol 2006;17:521–5.[Abstract/Free Full Text]
  11. Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, et al. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 1999;91:535–41.[Abstract/Free Full Text]
  12. Larsson SC, Håkansson N, Giovannucci E, Wolk A. Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. J Natl Cancer Inst 2006;98:407–13.[Abstract/Free Full Text]
  13. Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr 2000;130:129–32.[Abstract/Free Full Text]
  14. Kim YI. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 2004;13:511–9.[Abstract/Free Full Text]
  15. Duthie SJ. Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 1999;55:578–92.[Abstract/Free Full Text]
  16. Gonzalez CA, Riboli E, Badosa J, et al. Nutritional factors and gastric cancer in Spain. Am J Epidemiol 1994;139:466–73.[Abstract/Free Full Text]
  17. Harrison LE, Zhang ZF, Karpeh MS, Sun M, Kurtz RC. The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma: a case-control study in the U.S. Cancer 1997;80:1021–8.[CrossRef][Medline]
  18. Mayne ST, Risch HA, Dubrow R, et al. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 2001;10:1055–62.[Abstract/Free Full Text]
  19. La Vecchia C, Ferraroni M, D'Avanzo B, Decarli A, Franceschi S. Selected micronutrient intake and the risk of gastric cancer. Cancer Epidemiol Biomarkers Prev 1994;3:393–8.[Abstract]
  20. Lopez-Carrillo L, Lopez-Cervantes M, Ward MH, Bravo-Alvarado J, Ramirez-Espitia A. Nutrient intake and gastric cancer in Mexico. Int J Cancer 1999;83:601–5.[CrossRef][Medline]
  21. Chen H, Tucker KL, Graubard BI, et al. Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr Cancer 2002;42:33–40.[CrossRef][Medline]
  22. Nomura AM, Hankin JH, Kolonel LN, Wilkens LR, Goodman MT, Stemmermann GN. Case-control study of diet and other risk factors for gastric cancer in Hawaii (United States). Cancer Causes Control 2003;14:547–58.[CrossRef][Medline]
  23. Lissowska J, Gail MH, Pee D, et al. Diet and stomach cancer risk in Warsaw, Poland. Nutr Cancer 2004;48:149–59.[CrossRef][Medline]
  24. Botterweck AA, van den Brandt PA, Goldbohm RA. Vitamins, carotenoids, dietary fiber, and the risk of gastric carcinoma: results from a prospective study after 6.3 years of follow-up. Cancer 2000;88:737–48.[CrossRef][Medline]
  25. Halsted CH, Villanueva JA, Devlin AM, Chandler CJ. Metabolic interactions of alcohol and folate. J Nutr 2002;132:2367–72S.
  26. Hillman RS, Steinberg SE. The effects of alcohol on folate metabolism. Annu Rev Med 1982;33:345–54.[CrossRef][Medline]
  27. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 2002;132:2350–5S.
  28. Wolk A, Bergström R, Hunter D, et al. A prospective study of association of monounsaturated fat and other types of fat with risk of breast cancer. Arch Intern Med 1998;158:41–5.[Abstract/Free Full Text]
  29. Bergström L, Kylberg E, Hagman U, Erikson H, Bruce Å. The food composition database KOST: the National Administration's information system for nutritive values of food. Vår Föda 1991;43:439–47.
  30. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17–27.[Free Full Text]
  31. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305–13.[Medline]
  32. Ekström AM, Signorello LB, Hansson LE, Bergström R, Lindgren A, Nyrén O. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst 1999;91:786–90.[Abstract/Free Full Text]
  33. Hu FB, Stampfer MJ, Rimm E, et al. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 1999;149:531–40.[Abstract/Free Full Text]
  34. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall; 1984.
  35. Muñoz SE, Ferraroni M, La Vecchia C, Decarli A. Gastric cancer risk factors in subjects with family history. Cancer Epidemiol Biomarkers Prev 1997;6:137–40.[Abstract]



This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. E. Vollset, J. Igland, M. Jenab, A. Fredriksen, K. Meyer, S. Eussen, H. K. Gjessing, P. M. Ueland, G. Pera, N. Sala, et al.
The Association of Gastric Cancer Risk with Plasma Folate, Cobalamin, and Methylenetetrahydrofolate Reductase Polymorphisms in the European Prospective Investigation into Cancer and Nutrition
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2416 - 2424.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larsson, S. C.
Right arrow Articles by Wolk, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsson, S. C.
Right arrow Articles by Wolk, A.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation